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Abstract
Background: In the adult mammalian brain, neural stem cells (NSCs) proliferate in the dentate gyrus (DG) of the
hippocampus and generate new neurons throughout life. A multimodal protein, Galectin-1, is expressed in neural
progenitor cells (NPCs) and implicated in the proliferation of the NPCs in the DG. However, little is known about its
detailed expression profile in the NPCs and functions in adult neurogenesis in the DG.
Results: Our immunohistochemical and morphological analysis showed that Galectin-1 was expressed in the type
1 and 2a cells, which are putative NSCs, in the subgranular zone (SGZ) of the adult mouse DG. To study Galectin-
1’s function in adult hippocampal neurogenesis, we made galectin-1 knock-out mice on the C57BL6 background
and characterized the effects on neurogenesis. In the SGZ of the galectin-1 knock-out mice, increased numbers of
type 1 cells, DCX-positive immature progenitors, and NeuN-positive newborn neurons were observed. Using triple-
labeling immunohistochemistry and morphological analyses, we found that the proliferation of the type-1 cells was
increased in the SGZ of the galectin-1 knock-out mice, and we propose that this proliferation is the mechanism for
the net increase in the adult neurogenesis in these knock-out mice DG.
Conclusions: Galectin-1 is expressed in the neural stem cells and down-regulates neurogenesis in the adult
hippocampus.
Background
New neurons are continuously generated in the two neu-
rogenic regions of the adult mammalian brain: the sub-
granular zone (SGZ) of the hippocampal dentate gyrus
(DG) [1-3] and the subventricular zone (SVZ) of the lat-
eral ventricle [4-7]. The neurons arising in these two
systems have distinct roles in, respectively, odor discrimi-
nation or learning and memory [8-10]. Galectin-1 is
expressed in the neural progenitor cells (NPCs) in both
the SVZ of the lateral ventricle and the hippocampal
SGZ [11,12]. Recent studies from our group have shown
that Galectin-1 has therapeutic potential for treating neu-
rodegenerative disorders (i.e., brain ischemia and spinal
cord injury) via its ability to modulate neurogenesis
[13,14]. Thus, studying the function of Galectin-1 in
adult neurogenesis may contribute not only to elucidat-
ing the mechanism of adult neurogenesis but also to
developing therapeutic strategies for brain repair [15,16].
Galectin-1 has distinct functions that depend on its
redox state [17,18]. We reported that the reduced form
of Galectin-1 promotes the proliferation of the NSCs in
the SVZ through binding to the carbohydrate moieties
of b1 Integrin [12,19]. This Galectin-1 function is cru-
cial for functional recovery after brain ischemia [13]. On
the other hand, the oxidized form of Galectin-1, which
does not have the carbohydrate-binding activity, down-
regulates cell proliferation through the cell-cycle arrest
[20] of various cell types, including cerebellar astrocytes
[21]. However, the detailed expression patterns and
functions of Galectin-1 in adult hippocampal neurogen-
esis have been unclear.
Here, we studied the expression of Galectin-1 in the
adult hippocampal SGZ and its role in adult hippocampal
neurogenesis. We used multi-color immunohistochemistry
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to study neurogenesis in galectin-1 knock-out mice on the
C57BL/6 background, and found that Galectin-1 is
expressed in early-type NPCs of the adult mouse hippo-
campus and down-regulates neurogenesis.
Results
Galectin-1 was expressed in type 1 and 2a cells in the DG
of the adult mouse brain
Previous studies showed that Galectin-1 is expressed in
the hippocampal NPCs; however, the exact cell type(s)
that express Galectin-1 has not been clear [11,12]. Since
hippocampal neurogenesis has been well characterized
in C57BL/6 mice [22,23], we produced galectin-1 knock-
out mice on the C57BL/6 background using a speed
back-cross technique [24] combined with selection for
the enriched transmission of 64 microsatellite markers
that distinguish C57BL/6 from the 129 background
(Materials and Methods, See Additional file 1, Table 1).
A Galectin-1-specific antibody did not label tissue in
the galectin-1 knock-out mouse brain (Fig. 1 A-1B’), indi-
cating that our staining procedure was able to specifically
label Galectin-1 but not other proteins of Galectin family.
As we reported previously [12], Galectin-1+ cells were
found in the cortex, SVZ, and DG of the wild type con-
trol mouse brain (Fig. 1 C). To study which cell type(s) in
the DG expressed Galectin-1, we performed double-
immunostaining for Galectin-1 and several cell-type-
specific markers (Fig. 2 A), including GFAP, which is
expressed in the type 1 and 2a cells, Nestin and FABP7,
which are expressed in the type 1, 2a, and 2b cells [25],
and Musashi1 (Msi1), which is expressed in early-stage
NPCs [26,27]. Subsets of Galectin-1+ cells were positive
for GFAP (Fig. 2 B-B’’’, C), FABP7, Nestin, and Msi1 (Fig.
2 D-F). Cells expressing DCX, which are type 2b and 3
cells and immature neurons [25,28], and Calretinin,
which are post-mitotic immature neurons [29], were
never co-labeled with Galectin-1 (Fig. 2 G, H). Although
some NeuN+ interneurons in the hilus were Galectin-1+,
the NeuN+ cells in the SGZ and the granular cell layer
were not co-labeled with Galectin-1 (Fig. 2 I). PE-CAM1
+ cells, which are endothelial cells of blood vessels [30],
did not co-label with Galectin-1 in the DG (Fig. 2 J).
Taken together, these results suggest that, in the DG,
type 1 and/or 2a cells express Galectin-1.
Next, we examined the expression of Galectin-1 in the
type 1 and 2a cells more closely. Since the identification
criteria for type 1 cells depends on their morphology (a
triangular cell soma and an apical process) [25], and the
Galectin-1 immunoreactivity does not clearly stain cell
processes, we performed double-labeling with Galectin-1
and FABP7, GFAP, or Nestin, which are commonly used
for the morphological analysis of hippocampal progeni-
tors, to identify the type 1 cells [25] (also see Materials
and Methods). We found that the anti-FABP7 antibody
labeled both the cell soma and the processes of Galectin-
1+ cells more clearly than the anti-GFAP or anti-Nestin
antibody (Fig. 2 B’’’, D, E); therefore, we used the anti-
FABP7 antibody in the subsequent analyses.
Among the Galectin-1+ cells in the DG, 7.3% ± 1.4%
(n = 5 mice) had the characteristic triangular soma and
apical process of type 1 cells (Fig. 2 D, Materials and
Methods) [31]. The majority of the other Galectin-1+
cells had a non-radial cell shape, a small cell soma, and
an irregularly shaped nucleus, which are characteristics
of type 2 cells (Fig. 2 E, F) [31,32]. In the DG, of the
cells that showed the typical type-1 cell morphology,
33.1% ± 5.6% (n = 5 mice) expressed Galectin-1, indicat-
ing that a subset of the type 1 cells expresses Galectin-1.
Adult neurogenesis increased in the SGZ of the galectin-
1-null mutant mice
The expression pattern of Galectin-1 in the DG led us
to examine its function in the NPCs in adult hippocam-
pal neurogenesis. BrdU, which is incorporated by prolif-
erating cells, can be used to quantify adult neurogenesis
in the DG [28]. Therefore, we performed a series of
BrdU pulse-chase experiments [28] using the galectin-1-
null mutant mice and their control littermates. To study
each stage of NPC maturation separately, the mice were
sacrificed at two different time points after BrdU infu-
sion, and multi-color immunohistochemistry was per-
formed to visualize the incorporated BrdU in the
context of stage-specific marker expression (i.e., FABP7,
DCX, or NeuN) (Fig. 2 A).
Figure 1 Galectin-1 is expressed in the adult hippocampus. (A,
B) Galectin-1 (A) and nuclear (B) staining in the hippocampus of the
galectin-1-null mouse DG. (A’, B’) High-magnification images of the
boxed regions, respectively. No Galectin-1+ cells were detected in
the DG of galectin-1 null mutants, indicating that the staining was
specific for Galectin-1. (C) Low-magnification images of Galectin-1+
cells in a coronal section of the adult mouse brain. Galectin-1 was
expressed in the cortex, SVZ, and hippocampus. (Scale bars: A, B,
500 μm; A’, B’, 50 μm; C, 1000 μm).
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Figure 2 Galectin-1 is expressed in type 1 and 2a cells in the adult hippocampus. (A) Schematic diagram of neural marker expression in
the adult DG, correlated with neuronal cell stage. DG, dentate gyrus; LV, lateral ventricle; Gr, granule layer; SGZ, subgranular zone (B-C) Three-
dimensional reconstructions from confocal optical images of Galectin-1 (green) and GFAP (red) double-labeling, and Hoechst (blue) nuclear
staining in the hippocampus. (B) Galectin-1+/GFAP+ cells were seen in the DG (arrow). (C) A projected image from one optical slice of B. (D-J)
Galectin-1 expressed in type 1 and 2a cells in the adult DG. Arrows indicate FABP7 (red) and Galectin-1 (green) double-positive (yellow) cells (D),
Nestin (red) and Galectin-1 (green) double-positive (yellow) cells (E), and Msi1 (red) and Galectin-1 (green) double-positive (yellow) cells (F) in the
DG. (G) No co-labeling for Galectin-1+ (green; arrows) and DCX+ (red; arrowheads) in DG cells was seen. (H) Galectin-1+ (green; arrows) cells did
not express Calretinin (red; arrowhead). (I) Galectin-1 (green; arrows) was not expressed in NeuN+ (red) cells. Note the presence of Galectin-1-
positive interneurons in the hilus (arrowheads). (J) Galectin-1+ (green; arrowheads) cells did not express the blood vessel marker PE-CAM1 (red;
arrows). DG, dentate gyrus; LV, lateral ventricle; Gr, granule layer; SGZ, subgranular zone. (Scale bars: B-C, 10 μm; D-J, 5 μm).
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In the first BrdU-pulse chase experiment, BrdU was
injected every 3.3 hours for 10 hours, and the mice were
sacrificed 3.4 hours after the last injection (Fig. 3 A)
[12,33]. As previously described [28,34], in the control
DG, the BrdU+ cells were mainly early-stage NPCs (Fig.
3 D’). Interestingly, the total number of BrdU+ cells in
the SGZ was higher in the galectin-1-null mutant mice
(Fig. 3 B-C; P < 0.05; n = 5 mice each), as was the num-
ber of FABP7+/BrdU+ double-positive cells (Fig. 3 D,
D’; P < 0.05; n = 5 mice each). By morphological analy-
sis of these FABP7+/BrdU+ cells ([25]; Materials and
Methods), we found that the number of BrdU+ type 1
cells also increased in the galectin-1-null mutants (Fig. 3
E, F; P < 0.01; n = 5 mice each), suggesting that NSCs
also increased in the null mutant mouse DG.
In the second BrdU-pulse chase experiment, BrdU was
given in the drinking water for 7 days, and the mice
were sacrificed 10 days after the last day of BrdU
administration (Fig. 3 G) [28,34]. As expected, in the
wild-type DG, the BrdU+ cells were mostly late-stage
NPCs (Fig. 3 J’). The total number of BrdU+ cells in the
SGZ increased in the galectin-1 null mutants (Fig. 3 H-I;
P < 0.05; n > 5 mice each) as did the number of DCX
+/BrdU+ cells and NeuN+/BrdU+ cells (Fig. 3 J, J’; P <
0.05; n > 5 mice each). Taken together, these results
suggested that in the absence of Galectin-1, hippocam-
pal neurogenesis is increased.
Proliferation of type 1 and 2a cells was up-regulated in
the galectin-1-null mutant mice
To analyze the mechanism of the increased adult hippo-
campal neurogenesis in the galectin-1 null mutant mice,
we studied the proliferation status of NPCs in the SGZ
by multi-color immunohistochemistry. The total number
of Ki67+ cells was comparable between the galectin-1-
null mutants and their control littermates (Fig. 4 A-B;
P = 0.25; n > 5 mice each). However, triple-labeling
with Ki67, FABP7, and DCX revealed that the number
of proliferating FAPB7+/DCX- cells, which represent
cell types 1 and 2a (Fig. 4 A-A’’’’) [25], increased in the
galectin-1-null mutants (Fig. 4 A-A’’’’, C; P < 0.05; n > 5
mice each). On the other hand, the number of prolifer-
ating FABP7+/DCX+ cells, which represent the type 2b
cells, was comparable between the galectin-1-null
mutants and their control littermates (Fig. 4 C; P = 0.08;
n > 5 mice each) [25]. These results suggest that the
absence of Galectin-1 resulted in an increase of type 1
and/or 2a cell proliferation, but not of type 2b cell pro-
liferation in the DG.
To examine apoptosis in the adult neurogenic regions
of the galectin-1 null mutants, we performed immunos-
taining for cleaved-Caspase-3 (cv-Casp3), a marker for
apoptotic cells [35]. The total number of cv-Casp3+ cells
in the SGZ was comparable between the galectin-1-null
mutants and their control littermates (Fig. 4 D-E; P =
0.18; n > 22 mice each). In addition, the number of
FABP7/DCX/cv-Casp3 triple-positive cells, which repre-
sent apoptotic type 1 and 2a cells, was also comparable
(Fig. 4 D-D’’’’, F; P = 0.44; n > 22 mice each).
Collectively, these data suggest that the absence of
Galectin-1 resulted in an increase in the proliferation of
the type 1 and/or 2a cells in the DG of the galectin-1
null mutant mice.
Discussion
In this study, we showed that Galectin-1 is expressed in
early-type of NPCs (i.e., type 1 and 2a cells) in the adult
mouse hippocampus. By using galectin-1 knock-out
mice on the C57BL/6 background, we showed that
Galectin-1 is required for the normal proliferation of the
early NPCs of the adult hippocampus. These results
suggest that Galectin-1 suppresses the proliferation of
early-type of the NPCs during adult hippocampal neuro-
genesis (Fig. 5).
Recent studies reported that type 1 and 2a cells act as
stem cells in the adult DG [25,36-38]. Our immunohis-
tochemical and morphological studies showed that
Galectin-1 is expressed by a subset of type1 and 2a cells
in the DG, suggesting that Galectin-1 is expressed in
NSCs. We found that the increased proliferation in the
DG of galectin-1 null mutants led to larger numbers of
type 1 cells and their daughters, including newborn neu-
rons. Previous reports showed that Galectin-1 can regu-
late the cell-cycle and/or apoptosis, depending on the
biological context [20,39-41]. We found that although
the proliferation of the type 1 and 2a cells increased,
apoptosis of these cells remained normal in the galaec-
tin-1 knock-out mouse DG. These results suggest that
the increased numbers of type 1 and 2a cells, and their
progenies in the DG of the knockout mice was caused
by the increased proliferation of the type1 and 2a cells.
Surprisingly, our study showed an opposite function of
Galectin-1 in the adult DG compared with reports on
Galectin-1’s function in the adult SVZ [12,13]. Pre-
viously, Galectin-1 was reported to have biphasic func-
tions in cell growth, depending on its redox state [41].
At low concentrations (~1 ng/ml), Galectin-1 exists in
its reduced form and possesses a mitogenic activity; at
high concentrations (~10 μg/ml), Galecitn-1 is con-
verted to an oxidized form and arrests the cell-cycle
[20,42]. Consistent with these findings, relatively high
concentrations of Galectin-1 (1 and 10 μg/ml) decreased
the number of adult hippocampal NPCs in vitro (data
not shown). In contrast, low-concentration Galectin-1
(10 and 100 ng/ml) increases the number of SVZ NPCs
in vitro [12,19], and infusion of a reduced form of
Galectin-1 (CS-Galectin-1) promotes the proliferation of
NSCs in the adult SVZ in vivo [12]. These findings
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Figure 3 The number of NPCs in the DG was higher in the galectin-1 null mutant mouse than in controls. (A-D’) The increase in the
number of FABP7+/BrdU+ cells in the galectin-1 null mutant mouse brain was significant. (A) Time-line for the BrdU infusion experiment. BrdU
was infused every 3.3 hours for 10 hours, and the mice were sacrificed 3.4 hours after the last injection. (B, B’) BrdU+ cells in the DG of a
galectin-1-null mutant mouse (B’) and control (heterozygous) mouse (B). n = 5 mice each. Dotted lines outline the SGZ. (C) The number of BrdU
+ cells in the DG of the KO mice was greater than in their heterozygous littermates. P < 0.05; n = 5 mice each. (D) The number of FABP7+/BrdU
+ cells was greater in the DG of galectin-1 null mutant mice than in that of controls. P < 0.05; n = 5 mice each. (D’) Double-labeling for FABP7
(red) and BrdU (green). Arrowheads indicate double-labeled cells. (E) High-power image of FABP7+/BrdU+ double-labeled cells in the SGZ. (F)
The number of BrdU+/type 1 cells was greater in the galectin-1-null mutant mouse DG than in that of controls. P < 0.05; n = 5 mice each. (G)
Time-line for the long-term BrdU infusion experiment. BrdU was given for 7 days, and the mice were sacrificed 10 days after the last day of BrdU
administration. (H, H’) BrdU+ cells in the galectin-1 null mutant mouse DG (H’) and control mouse DG (H). P < 0.05; n = 5 mice each. Dotted
lines outline the SGZ. (I) The number of DCX+/BrdU+ cells was greater in the galectin-1-null mouse DG. P < 0.05; n = 5 mice each. (J)
Quantitative comparison of FABP7+/BrdU+, DCX+/BrdU+, and NeuN+/BrdU+ cells in the DG of the KO and control mice. Significant increases
were seen in the DCX+/BrdU+ and NeuN+/BrdU+ cells in the KO DG. (J’) Arrowheads indicate DCX (red) and BrdU (green) double-positive cells,
and the arrow indicates a BrdU single-positive cell. (Scale bars: B, B’, H, H’, 100 μm; D’, E, J’, 5 μm).
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Figure 4 The number of proliferating type 1 and 2a cells was greater in the galectin-1-null mutant DG than the control DG. (A-A’’’’)
High-magnification images of Ki67 (blue), FABP7 (green), and DCX (red) triple staining with nuclear Hoechst (white) in the DG. Arrow indicates a
Ki67+/FABP7+/DCX- cell. (B) The total number of Ki67+ cells was not different between the galectin-1 heterozygous and galectin-1-null mice.
P = 0.25; n > 5 mice each. (C) The number of Ki67+/FABP7+/DCX- cells was higher in the galectin-1 null mutants, suggesting that Galectin-1
negatively regulates the proliferation of type 1 and 2a cells in the adult DG. P < 0.05; n > 5 mice each. P < 0.01; n > 5 mice each. (D-D’’’’) High-
magnification images of cv-Casp3 (blue), FABP7 (green), and DCX (red) triple staining, with nuclear Hoechst (white) in the DG. Arrow indicates a
cv-Casp3+/FABP7+/DCX- cell. (E) The number of cv-Casp3+ cells was comparable between the galectin-1 heterozygous and KO mice. P = 0.12;
n > 11 mice each. (G) No significant difference between the number of cv-Casp3+/FABP7+/DCX- cells in the SGZ of galectin-1 KO and control
mice. n > 22 mice each. (Scale bars: A-A’’’’, D-F’’’’, 5 μm).
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suggest that the reduced form of Galectin-1 promotes
the proliferation of NPCs in the adult SVZ, whereas the
oxidized form of Galectin-1 inhibits the proliferation of
adult hippocampal NPCs. The validity of this hypothesis
will be clarified in a future study.
A recent report showed a decrease of BrdU-positive
NPCs in the DG of galectin-1 knockout mice on a 129
background [11]. Although 129 mouse lines are widely
used in biology, they are known to show poor hippocam-
pus-dependent learning [43,44], low levels of activity [45],
and altered long-term potentiation in hippocampal neu-
rons [46]. On the other hand, the adult hippocampal neu-
rogenesis in the C57BL/6 mouse is well characterized
[22,23]. The C57BL/6 line not only has a high rate of the
NPC proliferation in the SGZ but also displays experi-
ence-related regulation of cell survival and a comparatively
high rate of net neurogenesis in the adult DG [22,23]. To
avoid confounding data from background-dependent phe-
notypes, we generated the galectin-1 knock-out mouse
line on the C57BL/6 background for our analysis of the
expression and function of Galectin-1 in adult hippocam-
pal neurogenesis. This led to our identification of a new
function of Galectin-1 in adult hippocampal neurogenesis.
There are some molecules that function in both the
SVZ and DG in adult neurogenesis (TGFb, Notch
[47,48]); however, no molecule has been described to
date that functions in opposite directions in the two
neurogenic systems (i.e., up-regulates neurogenesis in
the SVZ and down-regulates it in the SGZ, as in Gale-
citn-1’s case). Our findings may help to elucidate differ-
ences in the mechanisms of neurogenesis in these two
major neurogenic regions of the adult brain [15,16].
Conclusions
Our study demonstrated that Galectin-1 was expressed
in the early-type NPCs (i.e. type 1 and 2a cells) in the
adult DG. Moreover, we showed that the number of
type 1 and 2a cells increased in the adult DG of the
galectin-1 knockout mice. These results suggest that
Galectin-1 negatively regulates the proliferation of the
early-type NPCs in adult hippocampal neurogenesis.
These findings represent a new step toward understand-
ing the mechanism of adult neurogenesis and toward
establishing new methods to repair the adult CNS after




Brains were perfusion-fixed with 4% paraformaldehyde
(PFA), postfixed in the same fixative overnight, and then
cut into 50-μm sections on a vibratome. After three
rinses in PBS, the sections were incubated for 20 min in
TNB blocking solution (Vector Laboratories), incubated
with primary antibodies overnight, and then incubated
for 60 min at room temperature with the Fab2-portion
of secondary antibodies (1:500; Jackson ImmunoRe-
search) conjugated with HRP (1:500; Jackson ImmunoR-
esearch) or Alexa Fluor (1:200; Molecular Probes),
unless otherwise noted. The biotin- and HRP-conjugated
antibodies were visualized using the Vectastain Elite
ABC kit and/or TSA (Vector Laboratories). For multi-
color labeling, the potential for the cross-reactivity of
the secondary antibodies with off-target primary antibo-
dies was carefully tested and excluded by using the
appropriate controls (e.g., parallel staining without one
of the primary antibodies).
Primary Antibodies
The primary antibodies (final dilution and source) used
in this study were as follows: mouse monoclonal
anti-GFAP (1:200, Sigma); rat monoclonal anti-Bromo-
deoxyuridine (BrdU) (1:250, Abcam); rabbit polyclonal
anti-Calretinin (1:100, Swant); goat polyclonal anti-DCX
(1:300, Santa Cruz Biotechnology); rabbit polyclonal
anti-PE-CAM-1 (1:100, Beckton Dickinson); rat mono-
clonal anti-Musashi1 (1:500, [26,49,50]); rabbit polyclo-
nal anti-FABP7 (1:200, Chemicon); rabbit polyclonal
anti-Ki67 (1:5000, Abcam); goat anti-Galectin-1 (1:200,
R&D Systems); mouse monoclonal anti-Nestin (1:100,
Developmental Studies Hybridoma Bank); mouse mono-
clonal anti-NeuN (1:100, Chemicon); and rabbit polyclo-
nal anti-cleaved-Caspase-3 (1:200, Cell Signaling
Technology).
BrdU pulse-chase labeling
For the short-term chase, mice were given i.p. injections
of BrdU (120 mg/kg dissolved in phosphate buffer;
Sigma) every 3.3 h for 10 h and were sacrificed 3.4 h
after the last injection. For the intermediate-term chase,
1 mg/ml BrdU was given to mice in their drinking
water for 1 or 2 weeks. The mice were killed 10 days
after the last day of BrdU administration, and the brains
were processed for immunohistochemistry.
Figure 5 Schematic diagram showing the expression and
function of Galectin-1 in adult neurogenesis in the DG.
Galectin-1 is expressed in type 1 and 2a cells and inhibits their
proliferation under normal conditions (left). In the galectin-1-null
mutant DG, the absence of Galectin-1 leads to an increased number
of neural precursor cells (right).
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Quantification of histological results
To quantify each cell type, 40 coronal vibratome sections of
the DG (50-μm thick) were obtained at the level of the cau-
date-putamen (1.2 to 3.2 mm caudal to the bregma) from
each hemisphere. In the BrdU experiments, the sections
were double labeled for FABP7/BrdU, DCX/BrdU, or
NeuN/BrdU. First, we counted the total BrdU-positive
nuclei (Apotome, Zeiss) in each section. Next, several
images were captured as 1.5-μm optical sections (LSM-510,
Zeiss), and the BrdU+ nuclei that were positive for each of
the markers (FABP7, DCX, NeuN) were counted. The total
number of BrdU+ cells was then multiplied by the ratio of
the cells of each type to BrdU+ cells, yielding the numbers
for each cell type, as follows: Type 1, 2a, 2b cells = total
number of BrdU+ (FABP7+/BrdU+); Type 2b, 3 cells and
immature neurons = total number of BrdU+ (DCX+/BrdU
+); and mature neurons = total number of BrdU+ (NeuN
+/BrdU+). For each experiment, the numbers of BrdU+
cells were normalized to the total number of BrdU+ cells in
a heterozygous mouse in a single 50-μm slice.
Proliferating cells were detected using an anti-Ki67 anti-
body. The sections were triple stained for FABP7, DCX,
and Ki67. We counted the total number of Ki67+ nuclei
(Apotome, Zeiss) in each vibratome section. Several
images were captured as 1.5-μm optical sections (LSM-
510, Zeiss), and the number of Ki67+ nuclei that were
positive for each of the markers (FABP7, DCX) was
counted. The total number of Ki67+ cells was multiplied
by the ratio of the cells of each type to Ki67+ cells, yielding
the number of each cell type, as follows: type 1, 2a cells =
total number of Ki67+ (FABP7+/DCX-/Ki67+); type 2b
cells = total number of Ki67+ (FABP7+/DCX+/Ki67+).
Apoptotic cells were detected using an anti-cv-Casp-3
antibody. The sections were triple stained for cleaved
Casp-3, FABP7, and DCX. We counted the total cv-
Casp-3-positive nuclei and the number of cv-Casp-3+
nuclei that were positive for each marker (FABP7, DCX),
as described above. The total number of cv-Casp-3+ cells
was multiplied by the ratio of the number of cells of each
type to cv-Casp-3+ cells, yielding the number of each cell
type, as follows: Type 1, 2a cells = total number of cv-
Casp-3+ (FABP7+/DCX-/cv-Casp-3+).
To quantify the type 1 cells, we counted the number of
FABP7+/Galectin-1+ (/Ki67+) or FABP7+/BrdU+ radial
glia-like cells, which have a triangular cell soma and apical
process, in the SGZ [25]. By following our criteria for the
type 1 cells, we found that only 7.1% ± 2.9% (n = 5 mice) of
the total type 1 cell population was proliferating in control
mice. This data are consistent with a previous report [28].
Generation of galectin-1 knock-out mice in the C57BL6/J
background
To generate galectin-1-null homozygous C57BL6/J mice
from 129SJ mice [51], we used the speed back-cross
technique [24] and monitored 64 microsatellite markers
from the Mouse Genome Informatics database (http://
www.informatics.jax.org/) that can be used to discern the
129SJ and C57BL/6J strains (See Additional file 1,
Table 1). The markers were analyzed using the ABI 3100
Genetic Analyzer, ABI GeneScan 3.7, and Genotyper 2.5
software. After the fifth backcrossing with selected mice
that showed the best B6-exchanged PCR results in each
backcross step, we obtained mice in which all 64 129SJ
markers had been replaced with the C57BL/6J markers.
Animals
For the adult mouse study, 8-week-old male mice were
killed by anesthetic overdose. We used heterozygous
mice as controls. Mice were maintained on a 12-h light/
12-h dark cycle with unlimited access to food and
water. All the experiments on live animals were per-
formed in accordance with Keio University guidelines
and regulations.
Statistical analysis
Values are expressed as the mean ± SE. An unpaired t-test
(for two groups) or ANOVA with the Bonferroni correc-
tion (for more than three groups) was used to evaluate the
differences between averages unless otherwise noted.
Additional material
Additional file 1: Table 1.
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